Patent Assignment
Reel/Frame 014218/0669
Security Interest
Recorded: 2003-12-24
Pages: 25
Assignor
SAGRES DISCOVERY, INC.
Executed: 2003-12-19
Assignees
FORWARD VENTURES IV, L.P.
9393 TOWNE CENTRE DRIVE, SUITE 200, SAN DIEGO, CALIFORNIA, 92121
FORWARD VENTURES IV B, L.P.
9393 TOWNE CENTRE DRIVE, SUITE 200, SAN DIEGO, CALIFORNIA, 92121
AXIOM VENTURE PARTNERS
185 ASYLUM STREET, 17TH FLOOR, HARTFORD, CONNECTICUT, 06103
BLUE DOT CAPITAL PTE LTD.
51 CUPPAGE ROAD, #09-01 STARHUB CENTRE, SINGAPORE, 229469, SINGAPORE
BURRILL BIOTECHNOLOGY CAPITAL FUND, L.P.
ONE EMBARCADERO CENTER, SUITE 2700, SAN FRANCISCO, CALIFORNIA, 94111
JAFCO G-8 (A) INVESTMENT ENTERPRISE PARTNERSHIP
TEKKO BLDG., 1-8-2, MARUNOUCHI, CHIYODA-KU, TOKYO 100-0005, JAPAN
JAFCO G-8 (B) INVESTMENT ENTERPRISE PARTNERSHIP
TEKKO BLDG., 1-8-2, MARUNOUCHI, CHIYODA-KU, TOKYO 100-0005, JAPAN
JAFCO G-C-1 INVESTMENT ENTERPRISE PARTNERSHIP
TEKKO BLDG., 1-8-2, MARUNOUCHI, CHIYODA-KU, TOKYO 100-0005, JAPAN
LOTUS BIOSCIENCE INVESTMENT HOLDINGS LTD.
C/O 9/F, CENTRAL BUILDING, 3 PEDDER STREET, CENTRAL, HONG KONG
NOVARTIS BIOVENTURES, LTD.
HURST HOLME, 12 TROTT ROAD, P.O. BOX HM 2899, HAMILTON, HM LX, BERMUDA
Covered Properties
(44)
Novel Compositions and Methods for Cancer
PCT:
PCT/US2002/033835 ↗
Novel Compositions and Methods for Cancer
PCT:
PCT/US2002/036071 ↗
Novel Compositions and Methods for Cancer
PCT:
PCT/US2002/038582 ↗
Novel Compositions and Methods for Cancer
PCT:
PCT/US2002/041414 ↗
Novel Compositions and Methods for Cancer
PCT:
PCT/US2002/041776 ↗
Novel Compositions and Methods for Cancer
PCT:
PCT/US2003/006146 ↗
Novel Compositions and Methods for Cancer
PCT:
PCT/US2003/006235 ↗
Novel Compositions and Methods in Cancer Associated with Altered Expression of KCNJ9
PCT:
PCT/US2003/007469 ↗
Novel Compositions and Methods in Cancer Associated with Altered Expression of Prlr
PCT:
PCT/US2003/007470 ↗
Novel Compositions and Methods in Cancer Associated with Altered Expression of MCM3AP
PCT:
PCT/US2003/008071 ↗
Novel Compositions and Methods in Cancer Associated with Altered Expression of TBX21
PCT:
PCT/US2003/008188 ↗
Novel Compositions and Methods in Cancer Assocated with Altered Exression of PRDM11
PCT:
PCT/US2003/008808 ↗
Novel Compositions and Methods in Cancer
PCT:
PCT/US2003/008919 ↗
Novel compositions and methods for cancer
Application:
09/997,722 →
Publication:
US 2004/0072154
Novel compositions and methods for cancer
Application:
10/004,113 →
Publication:
US 2003/0194702
Novel compositions and methods for cancer
Application:
10/034,650 →
Publication:
US 2003/0216558
Novel Compositions and Methods for Cancer
Novel compositions and methods for cancer
Application:
10/052,482 →
Publication:
US 2004/0072264
Novel compositions and methods for cancer
Application:
10/085,117 →
Publication:
US 2003/0232334
Novel Compositions and Methods for Cancer
Novel compositions and methods in cancer associated with altered expression of MCM3AP
Application:
10/105,612 →
Publication:
US 2003/0165878
Novel compositions and methods in cancer associated with altered expression of TBX21
Application:
10/105,613 →
Publication:
US 2003/0099963
Novel compositions and methods in cancer associated with altered expression of PRDM11
Application:
10/105,637 →
Publication:
US 2003/0087252
Novel Compositions and Methods in Cancer Associated with Altered Expression of KCNJ9
Novel Compositions and Methods in Cancer Associated with Altered Expression of Prlr
Novel compositions and methods in cancer
Application:
10/322,281 →
Publication:
US 2004/0126762
Novel therapeutic targets in cancer
Application:
10/322,696 →
Publication:
US 2004/0166490
Novel compositions and methods in cancer
Application:
10/330,773 →
Publication:
US 2006/0040262
Novel compositions and methods in cancer
Application:
10/331,053 →
Publication:
US 2004/0197778
Novel therapeutic targets in cancer
Application:
10/367,094 →
Publication:
US 2004/0170982
Novel therapeutic targets in cancer
Application:
10/388,838 →
Publication:
US 2004/0180344
Novel compositions and methods in cancer
Application:
10/394,948 →
Publication:
US 2004/0023267
Novel therapeutic targets in cancer
Application:
10/417,375 →
Publication:
US 2004/0219528
Novel Therapeutic Targets in Cancer
Novel therapeutic targets in cancer
Application:
10/663,431 →
Publication:
US 2007/0218071
Novel therapeutic targets in cancer
Application:
10/669,920 →
Publication:
US 2006/0194265
Novel therapeutic targets in cancer
Application:
10/670,914 →
Publication:
US 2009/0214542
Novel therapeutic targets in cancer
Application:
10/674,575 →
Publication:
US 2007/0161003
Novel compositions and methods in cancer
Application:
10/676,684 →
Publication:
US 2007/0281896
Novel compositions and methods in cancer
Application:
10/691,209 →
Novel compositions and methods in cancer
Application:
10/692,382 →
Publication:
US 2008/0039413
Fractal-forming alkylketene dimers for integral membrane protein crystal growth
Application:
60/506,125 →
RHO antibody and tag to purify cell surface proteins
Application:
60/506,304 →
Novel splice variants of human DKKL1
Application:
60/507,682 →
Related Assignments
(18)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 4, 2002
From: MORRIS, DAVID W.; ENGELHARD, ERIC K.
To: SAGRES DISCOVERY
Reel/Frame 012675/0773 →
Assignment of Assignor's Interest
Mar 25, 2002
From: ENGELHARD, ERIC K.; MORRIS, DAVID W.
To: SAGRES DISCOVERY
Reel/Frame 012747/0123 →
Assignment of Assignor's Interest
Jun 10, 2002
From: MORRIS, DAVID W.; ENGLEHARD, ERIC K.
To: SAGRES DISCOVERY
Reel/Frame 012971/0593 →
Assignment of Assignor's Interest
Jul 16, 2002
From: MORRIS, DAVID W.; ENGELHARD, ERIC K.
To: SAGRES DISCOVERY
Reel/Frame 013087/0631 →
Assignment of Assignor's Interest
Jul 16, 2002
From: MORRIS, DAVID W.; ENGELHARD, ERIC K.
To: SAGRES DISCOVERY
Reel/Frame 013087/0612 →
Assignment of Assignor's Interest
Jul 23, 2002
From: MORRIS, DAVID W.; ENGELHARD, ERIC K.
To: SAGRES DISCOVERY
Reel/Frame 013107/0801 →
Assignment of Assignor's Interest
Jul 29, 2002
From: MORRIS, DAVID W.; ENGELHARD, ERIC K.
To: SAGRES DISCOVERY
Reel/Frame 013130/0311 →
Assignment of Assignor's Interest
Jul 29, 2002
From: MORRIS, DAVID W.; ENGELHARD, ERIC K.
To: SAGRES DISCOVERY
Reel/Frame 013130/0322 →
Assignment of Assignor's Interest
Jul 30, 2002
From: MORRIS, DAVID W.; ENGELHARD, ERIC K.
To: SAGRES DISCOVERY
Reel/Frame 013141/0443 →
Assignment of Assignor's Interest
Aug 12, 2002
From: MORRIS, DAVID W.; ENGELHARD, ERIC K.
To: SAGRES DISCOVERY
Reel/Frame 013187/0198 →
Assignment of Assignor's Interest
Aug 21, 2002
From: MORRIS, DAVID W.; ENGELHARD, ERIC K.
To: SAGRES DISCOVERY
Reel/Frame 013219/0259 →
Assignment of Assignor's Interest
Sep 10, 2002
From: MORRIS, DAVID W.; ENGELHARD, ERIC K.
To: SAGRES DISCOVERY
Reel/Frame 013277/0374 →
Assignment of Assignor's Interest
Jul 31, 2003
From: MORRIS, DAVID W.; MALANDRO, MARC S.
To: SAGRES DISCOVERY, INC.
Reel/Frame 014335/0295 →
Assignment of Assignor's Interest
Oct 6, 2003
From: MORRIS, DAVID W.; MALANDRO, MARC S.
To: SAGRES DISCOVERY, INC.
Reel/Frame 014557/0920 →
Assignment of Assignor's Interest
Oct 10, 2003
From: MORRIS, DAVID W.; MALANDRO, MARC S.
To: SAGRES DISCOVERY, INC.
Reel/Frame 014577/0456 →
Assignment of Assignor's Interest
Oct 10, 2003
From: MORRIS, DAVID W.; MALANDRO, MARC S.
To: SAGRES DISCOVERY, INC.
Reel/Frame 014577/0454 →
Assignment of Assignor's Interest
Oct 20, 2003
From: MORRIS, DAVID W.; MALANDRO, MARC S.
To: SAGRES DISCOVERY, INC.
Reel/Frame 014608/0737 →
Assignment of Assignor's Interest
Jun 28, 2010
From: MORRIS, DAVID W; ENGELHARD, ERIC K
To: SAGRES DISCOVERY
Reel/Frame 024602/0551 →